LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
0.8305
-0.0470 (-5.36%)
At close: Sep 12, 2025, 4:00 PM EDT
0.8020
-0.0285 (-3.43%)
After-hours: Sep 12, 2025, 6:57 PM EDT

LakeShore Biopharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
3447136149233-
Market Cap Growth
-63.60%-65.52%-8.94%-36.18%--
Enterprise Value
8771176408373-
Last Close Price
0.832.457.2016.0067.97-
PS Ratio
0.190.080.240.220.46-
PB Ratio
0.250.090.230.200.35-
P/TBV Ratio
0.580.110.260.23--
EV/Sales Ratio
1.030.120.310.590.74-
Debt / Equity Ratio
0.830.830.730.690.570.02
Asset Turnover
0.430.430.360.440.39-
Inventory Turnover
0.500.500.940.830.90-
Quick Ratio
0.640.640.861.271.231.84
Current Ratio
1.021.021.131.571.612.13
Return on Equity (ROE)
-18.43%-18.43%-65.99%-40.50%-32.69%-
Return on Assets (ROA)
-2.15%-2.15%-13.85%-5.17%-5.46%-
Return on Capital (ROIC)
-3.22%-3.22%-20.01%-7.17%-7.71%-
Earnings Yield
-40.26%-213.88%-319.72%-190.38%-101.45%-
FCF Yield
-54.82%-285.98%-250.40%-157.98%-200.98%-
Buyback Yield / Dilution
-89.94%-79.18%-73.06%0.07%--
Updated Aug 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q